Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS) : A Phase IIb Clinical Trial.

NCT04925024 is registered in ClinicalTrials.gov with Longeveron Inc. as lead sponsor.

NCT NCT04925024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04925024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS) : A Phase IIb Clinical Trial.
Lead sponsor
Longeveron Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 25, 2021
Completion date
August 31, 2026
Enrollment
40 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypoplastic left heart syndrome